IP Library Granted Patent US 9,480,688
Granted Patent B2
US 9,480,688 · App. 14/826,948 · Granted Nov 1, 2016

Pheromone compositions and their use to modify behavior in different vertebrate species

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,480,688
App. No.
14/826,948
Granted
Nov 1, 2016
Kind
B2
Abstract

A composition comprising Androstenone is described for the modification of undesirable or harmful stress-related behaviors or other behaviors or physiology in a variety of vertebrate species, as well as methods of using the compositions in vertebrates from a species different than the species in which the Androstenone is a naturally occurring pheromone.

Claims (15)

1. A method of modifying behavior in a horse comprising: administering a pheromone composition to the horse as needed for a period of time, the composition comprising between about 0.001% and about 1% (w/w) of Androstenone, or a synthetic version thereof, and between about 0.5% and 99.99% (w/w) of at least one carrier solvent, wherein the amount of Androstenone administered to the horse is between about 1.0 pg/mL to about 1.0 g/mL, and wherein head shy behavior in the horse is reduced.

2. The method of claim 1 , wherein the method of administration is inhalation.

3. The method of claim 1 , wherein the composition further comprises a propellant.

4. The method of claim 1 , wherein the composition is formulated as a spray, an aerosol, a diffuser, or a slow release matrix.

5. The method of claim 4 , wherein administering the spray composition and the aerosol composition comprises spraying the horse or spraying the horse's environment with the composition.

6. The method of claim 1 , wherein the composition comprises at least one additional pheromone or pheromone composition.

7. The method of claim 1 , wherein the period of time is at least one second.

8. The method of claim 1 , wherein the period of time is at least one week.

9. The method of claim 1 , wherein the period of time is at least one month.

10. A method of modifying behavior in a horse comprising: administering an effective amount of a pheromone composition to the horse as needed for a period of time, the composition comprising between about 0.0001% and about 1% (w/w) Androstenone, or a synthetic version thereof, wherein anxiety, vocalization, and stress associated with weaning of the horse is reduced.

11. The method of claim 10 , wherein the composition is formulated as a gel, an ointment, or a cream.

12. The method of claim 10 , wherein administering the composition comprises topically applying an effective amount of the composition to the horse's nose, beneath the horse's nose, inside at least one of the horse's nostrils, or on the horse's body.

13. The method of claim 10 , wherein head-shaking, trotting, running, or pacing associated with weaning of the horse is reduced.

14. The method of claim 10 , wherein the feeding by the horse is increased.

15. The method of claim 11 , wherein the ointment composition comprises about 0.0001% (w/w) Androstenone, or a synthetic version thereof, about 87.9999% (w/w) petrolatum, about 10% (w/w) lanolin, and about 2% (w/w) cetyl alcohol.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: JEFFERIES FINANCE LLC
To: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT’S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
Reel/Frame 069052/0290 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: KEYBANK NATIONAL ASSOCIATION
To: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT’S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
Reel/Frame 069269/0614 →
FIRST LIEN PATENT SECURITY AGREEMENT (TL) Recorded Oct 28, 2024
From: PETIQ, INC.; PETIQ, LLC; TRURX LLC; VELCERA, LLC; FIDOPHARM, INC.; SERGEANT’S PET CARE PRODUCTS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069272/0659 →
ABL PATENT SECURITY AGREEMENT Recorded Oct 28, 2024
From: PETIQ, INC.; PETIQ, LLC; TRURX LLC; VELCERA, LLC; FIDOPHARM, INC.; SERGEANT’S PET CARE PRODUCTS, LLC
To: KEYBANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 069272/0670 →
SECURITY INTEREST Recorded Apr 14, 2021
From: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT'S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
To: JEFFERIES FINANCE LLC
Reel/Frame 055915/0408 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT R/F 049711/0975 Recorded Apr 14, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 055923/0978 →
ENTITY CONVERSION Recorded Oct 18, 2019
From: SERGEANT'S PET CARE PRODUCTS, INC.
To: SERGEANT'S PET CARE PRODUCTS, LLC
Reel/Frame 050767/0170 →
SECURITY INTEREST Recorded Jul 10, 2019
From: SERGEANT'S PET CARE PRODUCTS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049711/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2015
From: LEVIN, MARK; MCGLONE, JOHN J.
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 036394/0593 →